Newsletter | April 28, 2026

04.28.26 -- Structural Biology Wages War On HIV And The Pandemics Of Tomorrow

SPONSOR

Join Drug Discovery Chief Ray Dogum and an expert panelist group on May 5 at 11am ET for a virtual event on organ-on-chip advances. Learn how MPS platforms enhance efficacy, safety, ADME insights, and de-risk drug development. Registration is free thanks to sponsor Emulate.

FEATURED EDITORIAL

Structural Biology Wages War On HIV And The Pandemics Of Tomorrow

By Prem Prakash, Ph.D., Center for AIDS Health Disparities Research, Meharry Medical College

Imagine waking up to news of another outbreak — masks, lockdowns, lives upended. But what if we could stop the next one before it starts?

The Matchmaker Modality: Engineering Event-Driven Pharmacology With Induced Proximity

By Mahmoud Khatib Al-Ruweidi

Induced proximity has evolved into a versatile platform with the potential to change drug discovery, but challenges still remain.

INDUSTRY INSIGHTS

Advancements In Genome Integrity Assessment For Gene Therapies

Webinar | QIAGEN

Gene therapy holds promise for treating various genetic diseases. Explore the latest in gene therapy with expert insights on AAV vector integrity, dPCR-based solutions, and assay design.

Identify Lead Solid Form Early To Reduce Timelines And Downstream Costs

Q&A | Lonza

Devoting early-phase resources for solid form understanding and screening during a drug’s development lifecycle is critical, as doing so can help save time and resources on the path to market.

Accelerate Drug Discovery With Real-Time Cell Interaction Insights

Application Note | BD Biosciences

Decoding immune cell interactions reveals critical insights for cancer therapy. Advanced imaging and spectral analysis enable precise identification of synapses, accelerating immuno-oncology research.

Analytics And Bioassays Can Safely Fast-Track mRNA-LNP Development

Article | Cytiva

One main mRNA technology challenge is the formulation of delivery systems like lipid nanoparticles. Learn about evading impurities in lipids, the future of mRNA-based genomic medicines, and more.

New Technologies To Improve Solubility Of Brick Dust Compounds

Q&A | Lonza

David Lyon, Ph.D., and Molly Adam answer attendee questions from a recent webinar about three enabling technologies designed to improve drug solubility in organic solvents for spray drying.

SPONSOR

Driving Smarter Chemistry in Drug Discovery: Using Full DEL Data to Improve Early Compound Decisions

See the bigger picture in DEL screening data. This webinar explores how analyzing the full dataset, not just top hits, can uncover meaningful structure-function trends across chemical series. Learn how a broader view can sharpen early synthesis decisions, strengthen series selection, and help discovery teams prioritize smarter while reducing downstream risk in discovery programs. Click here to learn more.

SOLUTIONS

An Organ-Chip Platform That Generates Human-Relevant Data At Scale

Emulate

Discover Our DNA-Encoded Library (DEL) Technology

X-Chem